News Health

Vepdegestrant, an investigational estrogen receptor (ER) degrader, known as a proteolysis-targeting chimera (PROTAC ), outshone the commonly used selective estrogen ...

Trial Changes First-Line Approach for Most Common Breast Cancer Subtype

(MedPage Today) -- CHICAGO -- Incorporating the investigational, oral selective estrogen receptor degrader (SERD) camizestrant at the first sign of ...

Perioperative Durvalumab Plus FLOT Boosts EFS in Resectable Gastric/GEJ Cancer

(MedPage Today) -- CHICAGO -- Adding perioperative durvalumab (Imfinzi) to FLOT chemotherapy significantly improved event-free survival (EFS) compared with FLOT ...

Viral TikTok Trend for Weight Loss Is Harmful for Health

Share on Pinterest“Skinny Tok” is an extreme dieting trend on TikTok that equates thinness with health. Miodrag Ignjatovic/Getty Images“Skinny Tok,’ ...

Romesh Ranganathan opens up about mental health struggle

Annabel Rackham and Steven McIntoshCulture reportersBBCRanganathan said he used running, reading and breathing exercises to help centre himself when feeling ...

Does the TikTok “cure” really work?

Getty ImagesRuth CleggHealth and well-being reporterIt's a condition that affects more than 10 million people in the UK. It can ...

Disposable vapes ban begins but will teens quit?

The ban on the sale of single-use disposable vapes will come into force on Sunday across the UK, aimed at ...

What Was Billy Joel Diagnosed With?

(MedPage Today) -- You passed medical training, now see if you can pass our weekly quiz Source link : https://www.medpagetoday.com/quizzes/news-quiz/115830 ...

CAR T-Cell Therapy Boosts PFS in Advanced Gastric Cancer

TOPLINEIn patients with advanced Claudin-18 isoform 2 (CLDN18.2) -positive gastric or gastroesophageal junction cancers, satricabtagene autoleucel (satri-cel) chimeric antigen receptor ...

FDA Approves Moderna’s New Lower-Dose COVID-19 Vaccine

(MedPage Today) -- The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who ...

Post-Induction, Ponatinib Yields Molecular Response

In the treatment of newly diagnosed Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ ALL), patients who fail to achieve initial molecular ...

Worldwide Burden of Skin Cancer; Patient-Delivered Weight Loss Management

(MedPage Today) -- TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for ...

A Doctor’s Bias Creeps Into the Courtroom

(MedPage Today) -- I was recently called to jury duty in Washington, D.C. I had no idea what to expect ...

Sacituzumab or Chemo in First-Line TNBC: Which Is Better?

Treatment with pembrolizumab and the antibody-drug conjugate (ADC) sacituzumab govitecan improved progression-free survival (PFS) in patients with PD-L1-positive locally advanced ...

The Evidence

Why is it so hard to understand the effects a warming world has on our health? Source link : https://www.bbc.co.uk/sounds/play/w3ct70s9 ...

Chemo-Free Doublet in First-Line Boosts PFS in Triple-Negative Breast Cancer

(MedPage Today) -- CHICAGO -- Combining pembrolizumab (Keytruda) with sacituzumab govitecan (SG, Trodelvy) instead of chemotherapy as first-line treatment significantly ...

Novel Oral Agent for ESR1-Mutated Breast Cancer Boosts PFS in Second-Line

(MedPage Today) -- CHICAGO -- The investigational oral agent vepdegestrant more than doubled median progression-free survival (PFS) versus fulvestrant (Faslodex) ...

T-DXd Prevails in Trial of Second-Line Therapies for HER2 Gastroesophageal Cancer

(MedPage Today) -- CHICAGO -- Patients with progressive HER2-positive gastroesophageal (GE) cancer lived significantly longer when they received the antibody-drug ...

Gene-Driven Adjuvant Therapy for NSCLC Leads to Big Improvement in DFS